VHL and nonpapillary renal cell carcinoma: We generated two sunitinib-resistant clones (786-Su and A498-Su) from commercially available ccRCC cell lines that are deficient in VHL (786-O and A498) and characterized the biological and metabolic changes induced by sunitinib resistance.